Zeo ScientifiX (ZEOX) Cash from Financing Activities (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Cash from Financing Activities of $642000.0 for Q2 2026, up 1934.29% year-over-year from $31559.0 in Q2 2025, and down 50.39% quarter-over-quarter from $1.3 million in Q1 2026.
Zeo ScientifiX (ZEOX) Cash from Financing Activities (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Cash from Financing Activities history runs 15 years deep, the most recent figure standing at $642000.0 for Q2 2026.
- In Q2 2026, Cash from Financing Activities rose 1934.29% year-over-year to $642000.0; the TTM figure through Apr 2026 stood at $2.3 million (up 501.06% YoY), while the FY2025 annual figure was $305000.0, down 22.98% from the prior year.
- Cash from Financing Activities for Q2 2026 stood at $642000.0, down from $1.3 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $5.7 million in Q4 2022, with the low at -$1.0 million in Q1 2023.
- The 5-year median for Cash from Financing Activities is $188266.5 (2022), against an average of $547617.2.
- The sharpest annual moves came in 2023 and 2026: Cash from Financing Activities plunged 236.35% in 2023, then jumped 64800.0% in 2026.
- Zeo ScientifiX's Cash from Financing Activities stood at $5.7 million in 2022, then sank by 97.09% to $167000.0 in 2023, then slumped by 149.1% to -$82000.0 in 2024, then jumped by 453.66% to $290000.0 in 2025, then surged by 121.38% to $642000.0 in 2026.
- Business Quant data shows ZEOX's Cash from Financing Activities at $642000.0 in Q2 2026, $1.3 million in Q1 2026, and $290000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -6.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 36.24 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -16.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 27.18 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -273.15 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 642,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 642,000.00 |
| Apr 30, 2026 | 642,000.00 |
| Jan 31, 2026 | 1.29 Mn |
| Jan 31, 2026 | 1.29 Mn |
| Oct 31, 2025 | 290,000.00 |
| Oct 31, 2025 | 290,000.00 |
| Jul 31, 2025 | 52,000.00 |
| Jul 31, 2025 | 52,000.00 |
| Apr 30, 2025 | -35,000.00 |
| Apr 30, 2025 | -35,000.00 |
| Jan 31, 2025 | -2,000.00 |
| Jan 31, 2025 | -2,000.00 |
| Oct 31, 2024 | -82,000.00 |
| Oct 31, 2024 | -82,000.00 |
| Jul 31, 2024 | 498,000.00 |
| Jul 31, 2024 | 498,000.00 |
| Apr 30, 2024 | -11,000.00 |
| Apr 30, 2024 | -11,000.00 |
| Jan 31, 2024 | -9,000.00 |
| Jan 31, 2024 | -9,000.00 |